Webinar in Support of NSF Solicitation NSF 18-514 and NIH Solicitation RFA-TR-18-001
- 11:00 AM
GoToMeeting Overview and Welcome
- 11:10 AM
NSF Introduction
- 11:25 AM
NIH Introduction
NIH–the ISS National Lab Tissue Chips in Space
NCATS: Dan Tagle, PhD
[email protected]NIBIB: Šeila Selimović, PhD
[email protected] - 11:35 AM
The ISS National Lab Introduction
The ISS National Lab - NSF - NIH Webinar
NIH Solicitation
Chips in SpaceNSF Solicitation
NSF/the ISS National Lab Collaboration on Tissue Engineering on the ISS - 11:50 AM
Space Tango
Creating a New Commercial Enterprise in Low Earth Orbit
Twyman Clements; CEO & President
[email protected]
859-229-2719 - 12:00 PM
AECOM LASSO/KSC
Partnerships for the New Space Economy
Debbie Wells; Deputy Program Manager/Manager of Professional and Technical Services
[email protected]
321-861-2530 - 12:10 PM
STaARS, Inc.
STaARS Informational Presentation
Heath J. Mills, PhD.; Chief Executive Officer
[email protected]
770-312-3364 - 12:20 PM
Techshot, Inc.
Techshot Informational Presentation
Rich Boling; VP; Corporate Advancement
[email protected]
812-728-8136 - 12:30 PM
SpacePharma
SpacePharma Informational Presentation
Candice Hovell, PhD; Head of Research and Development
[email protected]
256-497-6212 - 12:40 PM
Bioserve Space Technologies
BioServe Space Technologies Informational Presentation
Stefanie Countryman, MBA; Associate Director
[email protected]
303-735-5308 - 12:50 PM
HNU-Photonics
HNu Photonics Informational Presentation
Devin Ridgley, PhD: Project Scientist
[email protected]
808-740-6125
Additional Presentations
NASA ARS
NASA Bioculture System
Paresh Bhavsar, PhD, Branch Chief
[email protected]
(note: not presented during webinar)
UG3/UH3 Mechanisms
Overview of Multi-Phase Milestone Application (UG3/UH3)
Christina Fleming, NCATS
(note: presented during 2016 webinar)
Scientific Review for NIH Grants
NIH-ISS National Lab Coordinated MPS Program for Translational Research in Space (UG3/UH3)
Christine Livingstone, NCATS
(note: presented during 2016 webinar)
Questions and Answers from Webinar
Q: Do advanced biomanufacturing applications have to be 3D geometry? Could applications based on 2D cell biomanufacturing questions be within the scope of the program?
A: NSF specific: In general advanced biomanufacturing applications should be 3D geometry to be responsive for EBMS. However please contact Michele Grimm [email protected] directly to discuss your potential application.
Q: Can the panel volunteer submit proposal as well?
A: NSF – No you may not serve as a panelist on the same panel you have submitted an application to. However, you may serve as a panelist on a NSF unsolicited proposal panel and submit a proposal for NSF-18-514.
A: NIH – No. Applications will be reviewed by a Special Emphasis Panel and reviewers may not have an application among those being reviewed.
Q: Would you please verify when is NIH deadline?
A: NIH Proposals Due Feb 8th 2018 @ 5pm local time
A: NSF Proposals Due Feb 12th 2018 @ 5pm local time
Q: Will this webinar be posted online afterward? And where?
A: Yes. Here and here.
Q: For clarification do we submit feasibility form before reaching out to IPs?
A: You should reach out to some IPs prior to submitting the feasibility review form. If you need assistance you can fill out as much of the form as you are able to and the ISS National Lab can send it to all the Implementation Partners and ask them to respond to you directly.
Q: Tissue engineering typically involves cells, question is can we culture/maintain cells in the space station?
A: Yes it is possible to culture and maintain cells in the space station. Please reach out to individual Implementation Partners in order to see how they might assist you in your particular cell culture needs.
Q: Are there fluorescence microscopy capabilities on board the ISS for the cell studies?
A: Yes there are capabilities to perform fluorescence microscopy on the space station. Please reach out to individual Implementation Partners in order to see how they might assist you in your particular requirements.
Q: Is there a desire that we work with multiple partners? If we find a good single match, is that good enough?
A: You may choose to work with one single implementation partner or a team of implementation partners. Either is acceptable.
Q: Can you go a little more into the logistics of the program along with some examples of past successes. I came in late, so if you already discussed please ignore this!
A: The NSF solicitation is a new funding opportunity, please refer to NSF 18-514 for details on the opportunity. The NIH solicitation is a reissue of RFA-TR-16-019. In the current FOA, RFA-TR-18-001, as well as here you can find details on prior awardees.